Tauopathy and cognitive impairment in experimental diabetes mellitus

Tauopathy and cognitive impairment in experimental diabetes mellitus

Currently, diabetes mellitus (DM) is the most common metabolic disorder, which is manifested by hyperglycemia and leads to vascular and cognitive impairment. Mechanisms of cognitive dysfunction in patients with DM remain highly unclear, thus complicating the search for effective strategies for the p...

Full description

Bibliographic Details
Main Authors:	Mariia V. Matveeva, Yulia G. SamoiIova, Natalia G. Zhukova, Oksana A. Oleynik, Maria A. Rotkank
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2017-08-01
Series:	Сахарный диабет
Subjects:	diabetes mellitus type 1 cognitive impairment tau protein alzheimer's disease
Online Access:	https://www.dia-endojournals.ru/jour/article/view/8282

Similar Items

Perspectives for cognitive rehabilitation of patients with diabetes mellitus
by: Mariia Matveeva, et al.
Published: (2016-12-01)

Glial contributions to neurodegeneration in tauopathies
by: Cheryl E. G. Leyns, et al.
Published: (2017-06-01)

PINK1 Alleviates Cognitive Impairments via Attenuating Pathological Tau Aggregation in a Mouse Model of Tauopathy
by: Xing Jun Jiang, et al.
Published: (2022-01-01)

Heparan Sulfate Proteoglycans in Tauopathy
by: Yanan Zhu, et al.
Published: (2022-11-01)

Astrocytes in Tauopathies
by: Matthew J. Reid, et al.
Published: (2020-09-01)

PET Imaging of Tau Pathology: Towards an affirmative diagnosis of Alzheimer’s and Tauopathies
by: Olga eJames, et al.
Published: (2015-03-01)

Targeting tauopathy with engineered tau-degrading intrabodies
by: Gilbert Gallardo, et al.
Published: (2019-10-01)

Interhemispheric asymmetry of the brain in patients with type 1 diabetes mellitus and cognitive impairment
by: Yulia Gennadevna Samoilova, et al.
Published: (2022-08-01)

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
by: Juan R. Perea, et al.
Published: (2018-07-01)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
by: Geraldine Zimmer-Bensch, et al.
Published: (2021-11-01)

Targeted Reducing of Tauopathy Alleviates Epileptic Seizures and Spatial Memory Impairment in an Optogenetically Inducible Mouse Model of Epilepsy
by: Yang Gao, et al.
Published: (2021-02-01)

A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
by: Caterina Giacomini, et al.
Published: (2018-05-01)

Integrated analysis of the aging brain transcriptome and proteome in tauopathy
by: Carl Grant Mangleburg, et al.
Published: (2020-09-01)

Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model
by: Sarah Houben, et al.
Published: (2019-07-01)

Tauopathies: A Distinct Class of Neurodegenerative Diseases
by: Ozansoy M, et al.
Published: (2007-01-01)

Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2018-03-01)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
by: Fangyang Jiao, et al.
Published: (2023-02-01)

Anti-inflammatory impact of minocycline in a mouse model of tauopathy
by: Claire J Garwood, et al.
Published: (2010-10-01)

Are tau aggregates toxic or protective in tauopathies?
by: Catherine M Cowan, et al.
Published: (2013-08-01)

NMR Studies of Tau Protein in Tauopathies
by: Kristine Kitoka, et al.
Published: (2021-11-01)

Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy
by: Megan A. Sealey, et al.
Published: (2017-09-01)

Spermidine/spermine-N 1-acetyltransferase ablation impacts tauopathy-induced polyamine stress response
by: Leslie A. Sandusky-Beltran, et al.
Published: (2019-06-01)

Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies
by: Pankajavalli Ramakrishnan, et al.
Published: (2003-11-01)

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
by: Andrea C. Klaver, et al.
Published: (2017-11-01)

Insulin-Mediated Changes in Tau Hyperphosphorylation and Autophagy in a Drosophila Model of Tauopathy and Neuroblastoma Cells
by: Shreyasi Chatterjee, et al.
Published: (2019-08-01)

TauLUM, an in vivo Drosophila sensor of tau multimerization, identifies neuroprotective interventions in tauopathy
by: Simon A. Levy, et al.
Published: (2022-09-01)

Inflammatory cytokines, oxidative stress, and tau protein impairment in cognitive functioning in patients with diabetes mellitus
by: Harpreet Kour, et al.
Published: (2024-08-01)

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis
by: Alex Zabala-Findlay, et al.
Published: (2023-04-01)

Using mass spectrometry to validate mouse models of tauopathy
by: Yan Yan, et al.
Published: (2023-04-01)

Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy
by: L. Arouche-Delaperche, et al.
Published: (2023-01-01)

Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2018-12-01)

The association of serum uric acid with cognitive impairment and ATN biomarkers
by: Shan Huang, et al.
Published: (2022-07-01)

Tauopathy in basal ganglia involvement is exacerbated in a subset of patients with Alzheimer's disease: The Hisayama study
by: Hideomi Hamasaki, et al.
Published: (2019-12-01)

Zonisamide Ameliorates Cognitive Impairment by Inhibiting ER Stress in a Mouse Model of Type 2 Diabetes Mellitus
by: Yong-Xiang He, et al.
Published: (2020-07-01)

RETRACTED: CSF p-tau as a potential cognition impairment biomarker in ALS
by: Zhongying Gong, et al.
Published: (2022-11-01)

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
by: Yuxing Xia, et al.
Published: (2020-06-01)

P-tau231 as a diagnostic biomarker for Alzheimer's Disease and mild cognitive impairment: A systematic review and meta-analysis
by: Fardin Nabizadeh, et al.
Published: (2022-01-01)

Novel autoimmune response in a tauopathy mouse model
by: Carlos J Nogueras-Ortiz, et al.
Published: (2014-01-01)

Selective degeneration of septal and hippocampal GABAergic neurons in a mouse model of amyloidosis and tauopathy
by: Desirée Loreth, et al.
Published: (2012-07-01)

NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
by: Natalia Shiryaev, et al.
Published: (2009-05-01)